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Abstract   51 
Angiostrongylus vasorum (A. vasorum) is an important emerging disease of canidae. 52 
Cardiorespiratory signs are common in affected dogs, therefore thoracic imaging is critical 53 
for diagnosing and monitoring disease. Descriptions of thoracic computed tomography (CT) 54 
findings in dogs naturally infected with A. vasorum are currently lacking. Aims of this 55 
multicentre, retrospective study were to findings in a group of dogs with confirmed disease, 56 
determine whether any changes were consistent among dogs, and propose standardized terms 57 
for describing thoracic CT findings. Nine UK-based referral centers’ clinical and imaging 58 
databases were searched for dogs that had a confirmed diagnosis of A. vasorum, and had 59 
undergone thoracic CT examination. Eighteen dogs, from seven of the centers, fulfilled the 60 
inclusion criteria.  The lung lobes were divided into the following three zones and the CT 61 
changes described in each: pleural (zone 1), subpleural (zone 2) and peribronchovascular 62 
(zone 3). The predominant abnormality was increased lung attenuation due to poorly defined 63 
ground glass opacity or consolidation. There were regions of mosaic attenuation due to 64 
peripheral bronchiectasis (6/18).  Nine/18 (50%) dogs showed hyper attenuating nodules of 65 
varying sizes with ill-defined margins.  The distribution always affected zone 1,2 with varied 66 
involvement of zone 3; this resulted in clear delineation between zones 2 and 3. 67 
Tracheobronchial lymphadenomegaly was frequently noted. Findings were non-specific and 68 
there was considerable overlap with other pulmonary conditions.  However, authors 69 
recommend that A. vasorum be considered a likely differential diagnosis for dogs with a 70 
predominantly peripheral distribution of ground glass opacity or mosaic attenuation. 71 
 72 
 73 
 74 
 75 
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Introduction 76 
Angiostrongylus vasorum (A. vasorum) is a nematodal endoparasite, belonging to the family 77 
Metastrongylidae, residing in the pulmonary arterial tree of domestic and wild canids. The 78 
nematode has a broad worldwide distribution including the United Kingdom (U.K.) and 79 
many regions of Europe, with specific foci of clinical disease within endemic regions.[1-13]  80 
Angiostrongylus vasorum has been recognized as a cause of many significant disease 81 
processes, including but not limited to cardiopulmonary disease, coagulopathies and 82 
neurological disease.[4, 14-21] Awareness of the aforesaid infection has consequently increased 83 
over the past decade by veterinary health professionals, the scientific community and the 84 
pharmaceutical industry. This array of clinical signs and the chronicity of the associated 85 
clinical signs may delay early detection and diagnosis of natural canine angiostrongylosis in 86 
many dogs.   The prognosis for infected dogs varies, with an estimated mortality rate of 2-87 
13% in a specialist referral facility despite appropriate treatment and intervention.[7, 15, 16, 22] 88 
Early and accurate diagnosis of infection is fundamental, thereby facilitating implementation 89 
of the appropriate therapeutic approach.  This is possible due to the numerous laboratory 90 
methods that are readily available, either as a in-house bedside test or via external laboratory 91 
testing.  92 
 93 
To date, clinical and experimental radiographic findings have been described in dogs with A. 94 
vasorum; radiographic findings are not pathognomonic for the interstitial pneumonia 95 
associated with the parasite. [23, 24] Thoracic computed tomography (CT) findings have only 96 
been reported in a series of six dogs experimentally infected with A. vasorum.  The findings 97 
included a pronounced multifocal peripheral alveolar pattern in all the dogs.  Additionally, 98 
there was evidence of nodular patterns and lung consolidation affecting areas of all lung 99 
lobes.  Such findings are reported to be dependent on the parasitic burden induced 100 
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experimentally. [25, 26]  It was suggested in the experimental study that a method to compare 101 
the degree of pulmonary changes should be developed.  It is very possible that natural 102 
infection differs from experimental disease given that disease in dogs can be chronic in 103 
nature, which may be associated with accumulative parasite numbers and the associated 104 
inflammatory reaction.  Additionally, the timing of presentation for investigation will differ 105 
based on clinical signs and on owner/veterinarian observations.  It is therefore unknown if the 106 
thoracic CT findings seen in experimentally infected dogs would be the same as those seen in 107 
dogs with natural infection presenting in a typical clinical setting on a less prescribed 108 
timeline. For this reason, there is a requirement to describe the imaging findings in naturally 109 
occurring infection of domestic canids.  110 
 111 
To the authors’ knowledge there is no literature describing the thoracic CT findings in a 112 
larger cohort of dogs naturally infected with A. vasorum. The overall goal of this study was to 113 
review the findings on thoracic CT in dogs naturally infected with A. vasorum.  Specific aims 114 
were to identify any consistent changes, while standardizing the description of thoracic CT 115 
findings. We hypothesized that some CT characteristics would be consistently detected in 116 
naturally infected dogs and that these would differ from those described in experimental dogs 117 
with acute infections and possibly higher worm burdens.     118 
 119 
Materials and Methods 120 
The study was a multi-center, retrospective, descriptive design.   The study consisted of a 121 
retrospective review of the clinical records and thoracic CT sequences for all dogs diagnosed 122 
with angiostrongylosis at nine United Kingdom and Ireland-based referral centers, between 123 
1st January 2010 and 1st July 2015 inclusively.   The relevant Ethics and Welfare committees 124 
granted approval for the retrospective study prior to publication.  Each of the institutes’ 125 
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clinical and imaging databases were searched for dogs that would fulfill the study criteria; 126 
using any of the keywords “Angiostrongylus vasorum A. vasorum, angiostrongylosis, 127 
lungworm, thoracic CT, parasitic pneumonia, and/or verminous”.  The following were 128 
inclusion criteria for this study: 129 
(1) A confirmed diagnosis of A. vasorum using at least one of the following 130 
modalities: faecal smear, Baermann examination with morphological identification, 131 
Bronchoalveolar lavage (BAL), point- of care ELISA test (Angiodetect™, IDEXX 132 
Europe B.V. P.O. Box 1334 NL -2130 EK Hoofddorp, The Netherlands), polymerase 133 
chain reaction (PCR), antibody detection, or laboratory verified antigen detection. 134 
(2) Complete clinical notes and the owners’ permission for their dogs to be 135 
included in the study. 136 
(3) Full thoracic CT scan (helical mode protocol). 137 
(4) The absence of previous diseases that could result in thoracic CT changes (e.g. 138 
congestive heart failure, or evidence of disseminated neoplasia). Ancillary tests 139 
utilised included but were not limited to; Bronchoalveolar lavage (BAL), 140 
bronchoscopy, biochemistry, haematology, echocardiography and coagulation 141 
profiles.  A positive diagnosis of A. vasorum was therefore identified as the 142 
aetiological cause for the clinical manifestations in each dog.   143 
Data recorded from the files included breed, gender, date of birth, number of dogs in 144 
household, travel history, concurrent disease(s), concurrent medication, associated clinical 145 
signs, laboratory data, CT and radiographic findings and clinical outcome of the dogs.  The 146 
presence or absence of respiratory signs (cough, tachypnea and dyspnea) were identified, and 147 
if present was noted as having an acute (<7days) or chronic onset (> 7days).  The dogs were 148 
grouped as juvenile (0-1 years), adult (1-6 years), or mature (6+ years) for descriptive 149 
statistics.  Categorization of their life stage was applied based on previously published 150 
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criteria.[27] 151 
As part of the inclusion criteria, CT studies of the full thorax were acquired with the dogs 152 
under general anesthesia or sedation using different third generation CT units (Siemens Dual 153 
Slice Somatom Spirit, Siemens AG, Arlangen, Germany;  GE Medical HighSpeed CT/e Dual, 154 
GE Medical Systems, Milwaukee, WI; GE Medical Brightspeed, GE Medical Systems, 155 
Milwaukee, WI; Philips MX8000 IDT 16, Philips Medical Systems, 5680 DA Best The 156 
Netherlands; Toshiba Aquilion Prime, Toshiba Medical Systems Europe B.V. Zoetermeer, 157 
The Netherlands; Siemens Emotion 16, Siemens AG, Arlangen, Germany) using helical scan 158 
protocol.  Similar protocols were used between the institutions including a high-and medium 159 
frequency spatial reconstruction algorithm, high kV (120-130) and appropriate mAs, patient 160 
size adjusted display field of view (FoV), pitch (0.8-1.8) and high-resolution reconstruction 161 
filters. Images were reconstructed at 0.5-5.0 mm slice thickness (Appendix 1).  Where 162 
contrast was administered, an intravenous infusion of iodinated contrast medium (XENETIX 163 
300mg I/ml (Iobitridol) solution for IV injection, Guerbet, France; Omnipaque 300mg I /ml 164 
(iohexol) solution for IV injection, GE Healthcare, Princeton, NJ 08540 USA) was 165 
administered via an indwelling intravenous cannula placed in the cephalic or saphenous veins 166 
at a dose of 2mL/kg.  The dogs were placed in sternal or right lateral recumbency for 167 
acquisition of the CT sequences. All dogs under general anaesthesia were ventilated as per 168 
the facilities breath hold protocols, thus minimising atelectasis and motion artefact during 169 
acquisition. 170 
 171 
The CT studies were reviewed independently by board-certified veterinary radiologist(s) at 172 
each referral center at the time of diagnosis, followed by a standardized retrospective 173 
assessment by one board-certified veterinary radiologist (GH).  The retrospective CT analysis 174 
was performed using a dedicated digital imaging and communications in medicine (DICOM) 175 
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workstation (Visbion Image viewer, Visbion, Visbion House, Surrey, UK) in both soft tissue 176 
and lung algorithms, with the window width (WW) and window level (WL) adjusted as 177 
required.  During the retrospective analysis, the radiologist was aware that all dogs had a 178 
diagnosis of angiostrongylosis, but was blinded to the severity of the presenting signs and 179 
other case information. 180 
The individual findings for each CT were classified based on the predominating pulmonary 181 
patterns.  Pulmonary CT changes were classified as per a previously described system for the 182 
assessment of CT findings of the canine lungs, after being adapted from human medicine.[25, 183 
28-31]  The lungs were divided into three zones: Zone 1, which is the pleural region, describes 184 
the 1mm area around the periphery of each lung lobe. Zone 2, which is the subpleural region 185 
of the lungs, describes the 5 per cent of the maximum lobar width of the lung parenchyma 186 
lying beneath the visceral pleura; Zone 3, defined as the peribronchovascular region contains 187 
the peribronchovascular interstitium that surrounds the central bronchi and pulmonary 188 
arteries, extends into the peripheral lung and incorporates the remaining lung that is not 189 
already included within the pleural and subpleural zones.  The lobes affected were described 190 
as single lobe, multiple lobes unilaterally or multiple lobes bilaterally. Pleural changes were 191 
defined as the capability to identify the pleura or pleural space on the images; such changes 192 
recorded could consist of ‘pleural thickening’; ‘enhancement’; or ‘effusion’.[32, 33] 193 
Abnormalities affecting each zone were further divided into the following categories: (a) 194 
linear and reticular; (b) nodules and nodular; (c) high attenuation: ground  glass opacification 195 
(GGO), consolidation, atelectasis and mineralization; (d) low attenuation: air trapping or 196 
cystic lesions (honeycombing, cysts, bullae, bronchiectasis and emphysema); (e) mosaic 197 
attenuation pattern- this appears as a patchwork of regions in different attenuation suggesting 198 
interstitial changes.  199 
 200 
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Thoracic CT findings for each dog were given a severity score: mild (1), moderate (2) and 201 
severe (3) which was assigned by our board-certified veterinary radiologist (Table 1).  202 
Additionally, other criteria included: lung lesions (solitary, lobar, diffuse, multifocal); 203 
number of lung lobes involved; vasculature changes (tortuous or thrombi) and 204 
tracheobronchial lymphadenopathy.  The pulmonary arterial diameter was compared to the 205 
accompanying bronchi, using the bronchoarterial ratio (BA Ratio), where individual 206 
bronchoarterial ratios in healthy dogs have been reported to range from 0.8 to 2.0. [34, 35]  The 207 
main pulmonary artery to aortic diameter ratio (MPA:Ao) was measured for each dog using 208 
CT measurements in the soft tissue window, to assess for presence of pulmonary 209 
hypertension.  The main pulmonary artery to aortic diameter ratio was assessed as previously 210 
described in the veterinary literature with a window level of 40HU and window width of 211 
350HU. The overall mean of the measured main pulmonary artery to aortic diameter ratio of 212 
normal dogs was 1.108 ± 0.152.[36] Contrast enhancement of any lesion(s) was characterized 213 
as homogenous or heterogeneous uptake.  Summary statistics were performed by one author 214 
(M.C.) using commercially available software (Excel, Microscoft Office).  The results were 215 
reported in the paper as mean, median and range (μ ± σ), where μ is the arithmetic mean and 216 
σ is the standard deviation.  217 
  218 
 219 
Results 220 
Seven of the nine centers (The University of Glasgow, Small Animal Hospital; The Royal 221 
Veterinary College, Hawkshead Lane; Anderson Moores, The Granary, Bunstead Barns; 222 
University of Liverpool, School of Veterinary Science, Leahurst Campus; Pride Veterinary 223 
Centre, Riverside Road; School of Veterinary Medicine and Science, University of 224 
Nottingham, Sutton Bonington Campus; University of Bristol, Langford Veterinary Services)225 
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in the Unitied Kingdom provided the cases for the study, following determination of 226 
suitability.  Twenty dogs (20) were originally identified; however, two dogs (2) were 227 
excluded, as they did not fulfil the inclusion criteria.  Therefore, eighteen dogs (18) with 228 
confirmed canine angiostrongylosis were included in this study.  Of these, 17/18 dogs were 229 
anaesthetized for CT exam; 1/18 dog was sedated for the imaging.  A total of 17/18 dogs 230 
were placed in sternal recumbency and 1/18 placed in right lateral for acquisition of the 231 
scans. All eighteen dogs had a diagnosis established within 5 days of the CT imaging. 232 
All dogs recovered uneventfully following the procedure.   A contrast agent was administered 233 
in 11/18 animals (as described earlier); no complications were associated following 234 
administration of the agent in any dog.  The dogs ranged in age from 6 months to 12 years 4 235 
months; the median age was 7 years 3 months. Sex distribution was male entire (6/18, 33%), 236 
male neutered (4/18, 22%), female entire (3/18, 17%) and female neutered (5/18, 28%).  The 237 
clinical signs included: acute respiratory distress (11/18, 61%); exercise intolerance (9/18, 238 
50%); coughing (8/18, 44%); bleeding diathesis (3/18, 16.7%); neurological dysfunction 239 
(3/18, 16.7%); weight loss (3/18, 16.7%) and pyrexia (2/18, 11%).    A total of 3/18 dogs had 240 
the absence of respiratory signs and were presented for the investigation of bleeding diathesis 241 
or neurological assessment only. The reader is invited to refer to the further demographic 242 
results and clinical findings of the population which are shown in Appendix 2.   243 
Bronchoscopy was undertaken and a Bronchoalveolar lavage conducted as part of the initial 244 
investigations in 15/18 dogs. Cytological examination of the Bronchoalveolar lavage shows a 245 
mixed inflammatory cell population (13/15), isolation of angiostrongylus larvae (10/15), 246 
pyogranulomatous inflammation on lung aspirates (2/15) and a positive culture for 247 
Pasteurella sp. and E. coli sp. (2/15).  Fourteen (14) dogs had non-specific changes on blood 248 
biochemical analysis. Hematological changes were observed in 12/18 animals, with 249 
eosinophilia, anemia and monocytosis being the most frequently observed anomalies.  Other 250 
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changes included thrombocytopenia and neutrophilia.  Of the three dogs presented for a 251 
suspected coagulopathy only two had detectable changes: one with prolonged activated 252 
partial thromboplastin time (APPT) and the other had altered platelet function identified 253 
using the multiplate analyser (Multiplate analyser: Roche Diagnostics International Ltd 254 
CH-6343 Rotkreuz, Switzerland).  255 
 256 
The dogs were treated as follows: fenbendazole (11/18), imidacloprid /moxidectin (2/18) or a 257 
combination of fenbendazole and imidacloprid /moxidectin (5/18).  Various supportive 258 
medications were given prior to CT examination, these included corticosteroids, theophylline 259 
and broad-spectrum antibiotics. The time between onset of clinical signs and CT examination 260 
varied in each dog from days to two weeks. Treatment with supportive therapy and 261 
anthelmintic led to complete resolution of the clinical signs in thirteen dogs (13/18), while 262 
clinical response was unknown in four dogs.  One dogs’ respiratory signs resolved with the 263 
treatment provided, however this dog was later euthanized for unknown reasons, at the 264 
owner’s request.   265 
 266 
All dogs (18/18) demonstrated evidence of lung lesions on CT, located within the right 267 
cranial, caudal, accessory, and left caudal lobes; the right middle and left cranial lobes were 268 
affected in 16/18 dogs.  All dogs had increased attenuation within the pleural region (zone 1) 269 
(18/18). These severely affected regions lay within the dorsal, mid and ventral aspects of the 270 
lungs; the dorsal and ventral aspects were most severely affected (16/18).  The most notable 271 
feature identified within the subpleural region (zone 2) was a multifocal to diffuse increase in 272 
lung attenuation in fourteen dogs. There was a dorsal or ventral predilection for lesion 273 
location noted on the CT examinations. On the CT images the main finding affecting the 274 
peribronchovascular region (zone 3) was an increased attenuation of the parenchyma in 15/18 275 
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dogs.  The changes noted within zone 3 of the lungs appear to be an extension from zone 2 276 
(7/18) and multifocal / diffuse in the other dogs.  The caudal lobes were severely affected by 277 
this peribronchovascular distribution (11/18), with a multifocal distribution affecting all lobes 278 
(4/18) or individual lobes (3/18). In moderate (CT score 2) to severe (CT score 3) dogs 279 
(6/18), there was mosaic attenuation of poorly circumscribed ground glass opacity to 280 
consolidation. Concurrent bronchiectasis was also seen (6/18). There was subtle subjective 281 
peribronchovascular thickening (peribronchial cuffing). The bronchiectatic changes were 282 
subjectively characterized, following the identification of air trapping within the smaller 283 
airways resulting in hypoattenuating regions on CT (the dilated bronchioles can result in 284 
cylindrical or cyst-like lesions). There was evidence of small to medium sized airways 285 
extending to the periphery of the lung lobes (zone 2) without apparent tapering in diameter, 286 
supportive of bronchiectasis (6/18).  These small airways were visualized at the periphery – 287 
surrounded by ground glass opacity or consolidation. 288 
 289 
Zone 1 demonstrated multifocal linear and reticular patterns with parenchymal bands, 290 
extending from the visceral pleura, in 14/18 dogs (Fig. 1A, B). The most notable feature 291 
identified zone 2 was a multifocal to diffuse increase in lung attenuation suggestive of poorly 292 
circumscribed ground glass opacity in fourteen dogs (14/18), with base wide wedge-shaped 293 
areas of consolidation noted in these dogs; these appear widest towards the periphery of each 294 
lobe (15/18) (Fig.2A, B). Ill-defined hyper-attenuating nodules ranging in size from small 295 
(3mm) to large (85mm) were observed throughout the parenchyma with a random 296 
distribution (9/18); no obvious dorsal or ventral predilection was noted (Fig.3A, B).  All 297 
nodules had hazy margins with heterogeneous attenuation on unenhanced lung window (HU: 298 
-136 to HU:36).  On the CT examinations, the main findings affecting zone 3 was an 299 
increased attenuation of the parenchyma with a generalized admixed consolidation (15/18) 300 
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and ground glass opacity (15/18).  301 
 302 
Additional CT findings included moderate tracheobronchial lymph node enlargement 303 
(16/18), mild to moderate cranial mediastinal lymphadenomegaly (6/18), cardiomegaly (1/18) 304 
and pneumomediastinum (1/18).  There was evidence of pulmonary arterial dilation in four 305 
dogs (4/18) with a reduction in bronchoarterial ratio of 1.1, 1.3, 1.1, 1.12 respectively. Six 306 
dogs exhibited an increased bronchoarterial ratio, suggestive of bronchiectasis. The results 307 
were: 1.6, 1.66, 1.75, 1.77, 1.77, 2.1 respectively.  The mean bronchoarterial ration in the 308 
eighteen dogs was 1.44. The main pulmonary artery to aortic diameter ratio measurement was 309 
similar in eighteen dogs, with a mean of 1.02 and median value of 0.99.  There was no 310 
evidence of pleural effusion noted in any of the dogs reviewed in this series.  311 
 312 
Discussion 313 
The CT findings in this study were comparable, yet not identical to, those observed in dogs 314 
with both low-grade and high-grade experimental A. vasorum infections.[25]  Dogs naturally 315 
infected with A. vasorum demonstrated the following CT features: predominately a diffuse to 316 
multi-centric, increased lung attenuation affecting multiple lobes.  In addition, these dogs 317 
developed a marked consolidation in the ventral aspect of the lobes of soft tissue attenuation; 318 
as in the previous study. Thoracic CT was conducted in all eighteen dogs to facilitate 319 
investigation of respiratory signs or to further assess for systemic or neoplastic/ metastatic 320 
disease responsible for the clinical manifestations.  Pulmonary changes were detected on CT 321 
examination for all eighteen dogs in this study –   respiratory signs were absent in three dogs 322 
at the time of initial presentation.  These three dogs demonstrated mild to moderate 323 
pulmonary changes on CT examination (severity score 1-2).  Thus, the severity of the 324 
respiratory signs did not appear to relate to the imaging findings on thoracic CT. 325 
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 326 
The previous study conducted in beagles showed a moderate, multi-centric ground glass 327 
opacity with nodule formations of varying sizes and consolidated regions of the lungs.   328 
These regions of consolidation were well demarcated with a geometric appearance 329 
resembling a wedge shape. The region of consolidation was widest towards the periphery of 330 
the lungs. The high-grade infected dogs demonstrated severe changes; which were 331 
comparable to the low-grade infected group but more profound.  The documented findings 332 
included large, coalescing nodules with larger areas of consolidation.  These affected areas 333 
were surrounded by a rim of ground glass opacity.  The dogs with high-inoculated levels of 334 
the parasite developed pleural fissure signs suggestive of effusion or pleuritis.   These signs 335 
were not seen in this study of naturally infected dogs  336 
 337 
In the previous study, all dogs had prominence of the regional lymph nodes 338 
(tracheobronchial, mediastinal and retrosternal) suggestive of lymphadenomegaly. The 339 
tracheobronchial lymphadenomegaly noted in the previous literature was not a consistent 340 
finding in this study of naturally infected dogs, but (16/18) of the dogs did demonstrate 341 
tracheobronchial lymph node enlargement. There was normal attenuation and tapering of the 342 
pulmonary vasculature in the experimental study, however the pulmonary arteries close to the 343 
nodules and wedge shaped parenchymal changes demonstrated filling defects.  These 344 
changes were interpreted as intraluminal thrombi secondary to the parasitic infestation. We 345 
could identify similar changes on retrospective analysis of CT imaging, while quantitatively 346 
and descriptively documenting the location and type of changes in each dog.   347 
 348 
Zone 1 demonstrated heightened attenuation; such findings may be suggestive of pleural 349 
thickening or a small volume of effusion, which was a consistent finding in all dogs.   The 350 
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parenchymal bands, seen as non-tapering, reticular hyperattenuating opacities, that extend 351 
from the visceral pleural (zone 1) may be the result of fibrosis and thickening of the 352 
interstitial fiber network of the lung periphery. The changes may suggest fluid, fibrous tissue 353 
or interstitial cellular infiltration, but would require histopathology for confirmation. [37, 38]  354 
Unfortunately, antemortem biopsies of focal lesion(s) may be representation of salient 355 
changes, and may not be demonstrative of the entire lung as an entity. The ground glass 356 
opacity in the peripheral regions of the lungs (zone 2) may be the result of thickening of 357 
subpleural interstitium, or inflammatory cell infiltrates within the interstitium or alveolar air 358 
space, thus resulting in consolidation. The peripheral lung changes are likely to be associated 359 
with multiple granulomatous lesions centered around the margination of parasite eggs and 360 
larvae of A. vasorum in the periphery at the lung capillaries.  The alveolar changes may be 361 
the result of the L1 larvae moving into the alveoli and smaller bronchioles.  The lifecycle of 362 
this nematode (namely the eggs and L1 larvae) are likely responsible for the distribution 363 
observed.[38, 39] 364 
 365 
The mean bronchoarterial ratio deduced in the previous study was 1.45 ± 0.21 (confidence 366 
intervals = 1.34–1.56) for healthy, non-brachycephalic dogs, while the individual 367 
bronchoarterial ratios in healthy dogs ranged from 0.8 to 2.0. [34, 35]   Notwithstanding the fact 368 
that the dogs in the study did not have convincing intraluminal filling defects of the 369 
pulmonary vasculature, there were changes suggestive of pulmonary arterial dilation. The 370 
objective assessment for pulmonary hypertension - main pulmonary artery to aortic diameter 371 
ratio ratio-  was interpreted as normal for each dog in this current study.  However, the 372 
normal range was based on a paucity of cases, consisting of ten healthy dogs in the previous 373 
study.  The mean of the measured main pulmonary artery to aortic diameter ratio determined 374 
by examination of thoracic CT sequences was 1.108 ± 0.152.[36]  In the previous study, it was  375 
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uncertain if a reference range could be extrapolated from the results in a small cohort of dogs, 376 
however, a ratio of >1.1 could be interpreted as being normal when calculated from CT 377 
measurements in healthy dogs.  The reliability of the measurement to deduce if a dog is 378 
suffering from pulmonary hypertension is uncertain from the previous study.[36]    To date, 379 
echocardiography is described as a reliable and non-invasive method to estimate pulmonary 380 
arterial parameters that can be used to deduce if pulmonary arterial hypertension is present.  381 
 382 
A complete assessment for pulmonary arterial hypertension includes evaluation of the 383 
pulmonary vasculature, cardiac evaluation, and evaluation of lung parenchyma. The 384 
identification of several anomalies will provide support for reliably diagnosing pulmonary 385 
hypertension.[36, 40-42]  Towards the periphery it was difficult to observe the smaller 386 
pulmonary arteries due to effacement resulting from the increased attenuation. Therefore, 387 
filling defects and thrombi may be easily overlooked. Subjective bronchiectasis was 388 
observed, however only one dog has bronchoarterial ratio > 2 which would be conclusive for 389 
bronchiectasis.  There is evidence of dilated, blunt ending airways extending into the 390 
periphery of the lung parenchyma (zone 2) resulting in a mixed attenuation (mosaic), 391 
consequently resembling cylindrical bronchiectasis.  The smaller airways, bronchioles, 392 
should not be observed in the 10mm peripheral region of the normal canine lungs [35]; this 393 
may be associated with chronic pathology and fibrosis resulting in traction bronchiectasis.  394 
The nodules that were observed had a random distribution, with ill-defined margins.  The 395 
attenuation was not solely soft tissue and resembled that of ground glass opacity, therefore 396 
was suggestive of an admix of air and fluid. The immunopathogenesis of canine 397 
angiostrongylosis is reported: deposits of immunoglobulins, complement and fibrinogen have 398 
been detected in the lungs of affected dogs.   This inflammatory response is proposed to be 399 
caused by the migration of larvae throughout pulmonary tissue and leads to multifocal 400 
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granulomatous pneumonia (with variable amounts of suppurative and eosinophilic 401 
inflammation).     In some dogs, the migrating larvae crossing into the airspace of the alveoli 402 
result in pulmonary hemorrhage. [1, 3-5, 11, 12, 21, 38, 43-45] 403 
 404 
One dog showed signs consistent with pneumomediastinum, which can be associated with 405 
bronchial, tracheal or alveolar pathology (most notably rupture).  Spontaneous 406 
pneumomediastinum has been noted in greyhounds without associated clinical signs. In such 407 
dogs the source of the gas is often obscure.[46] Since the affected dog was a greyhound, the 408 
significance of this finding is unknown and may be incidental.  Notably, the ventral aspects 409 
of the lung lobes were severely affected in 16/18 dogs; equally, this was identified in a 410 
previous study.  The distribution was believed to relate to pathology resulting in 411 
consolidation, due to the characteristics and extent of the changes on CT. Our goal was to 412 
identify any consistent changes on the CT examinations. The findings - peripheral, ventral 413 
and caudal distribution of ground glass opacity and nodules - described in this study are 414 
highly suggestive of A. vasorum; however, differential diagnosis of the heterogeneous hyper-415 
attenuating pulmonary nodules and ground glass opacity include eosinophilic 416 
bronchopnemopathy, pulmonary lymphoma, granulomatous lung disease and intrathoracic 417 
histiocytic sarcoma.[32, 40-42, 47]  418 
 419 
It has been suggested that younger dogs (often under the age of eighteen months) are more 420 
likely to show clinical manifestations following infection with A. vasorum, with the highest 421 
proportion of dogs under the age of eighteen months.  This occurrence in younger animals 422 
could be attributed to age-related tendencies and behaviour, or incomplete immunity. [3, 15, 48 423 
48, 49]  The majority of dogs in the study, albeit a small population, were adults (5/18) or 424 
mature adults (11/18), which did not reflect the distribution noted in previous studies.[15, 16] 425 
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The difference in distribution of age observed in our group of dogs could relate to older 426 
animals being immune-compromised due to factors such as concurrent infection or disease 427 
(although there was no evidence for this), or they may be immune-naïve if the parasite has 428 
recently emerged in that area.  A lack of owner awareness of clinical signs and inadequate 429 
prophylactic anthelmintic control may also result in significant parasitic burdens in areas 430 
recently colonised by the parasite.  It is possible that the parasitic burden may be 431 
accumulative with time, resulting in higher burdens in older animals.  Additionally, some of 432 
the younger dogs may have presented with acute or pathognomonic clinical signs at a 433 
primary care facility and may have been treated earlier, thus not requiring investigations at a 434 
referral level, or requiring a thoracic CT for further investigation.  From a diagnostic imaging 435 
viewpoint, the age distribution seen in this study means that metastrongyloid disease should 436 
appear on differential lists when similar CT findings are reported, even when the age 437 
demographic makes other differentials (such as neoplasia) seem more likely.  438 
 439 
Due to the limited number of dogs, summary statistics were conducted and the findings are 440 
purely descriptive.  The involvement of seven referral centres allowed for increased 441 
enrolment of dogs, however this meant that the thoracic CT studies were acquired in different 442 
facilities.  As such, there was reduced capability for standardisation of the CT scan protocols. 443 
Although the thoracic CT was conducted within 14 days of a diagnosis with A. vasorum, 444 
there may have been delayed diagnosis, meaning that each animal may have been at a 445 
different stages of disease progression.  A single board-certified veterinary radiologist 446 
reviewed the images to improve standardisation of the descriptive terms. The radiologist was 447 
not blinded to the clinical diagnosis when analysing the sequences. Atelectasis, whether 448 
passive, compressive or cicatrisation should be considered at least as a contributing cause for 449 
this distribution of abnormalities within the lungs.  Owing to the general anesthesia and 450 
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sternal positioning for acquisition of the CT exam, passive atelectasis is likely where there is 451 
a decreased lung volume. General anesthesia may result in notable alterations in aeration and 452 
may need to increased opacity of the lungs in the dependent lung fields. Unfortunately, 453 
atelectasis can prove difficult to eliminate, especially during prolonged procedures. CT 454 
examinations are routinely conducted prior to procedures to minimize incomplete expansion 455 
of the lungs and development of atelectasis.  By convention, all centers conducted a single 456 
breath hold protocol prior to the CT, usually with a positive pressure of 15-20cmH2O.  This 457 
was conducted for more consistent lung inflation and to reduce motion artefact. One dog 458 
(1/18) presented with acute dyspnea, the dog was placed in right lateral recumbency for 459 
acquisition of the study because its respiratory signs were improved in this position.  460 
 461 
A diagnosis of A. vasorum was reached following a positive result using at least one ancillary 462 
test, while showing compatible symptoms.   Bronchoalveolar lavage was conducted in fifteen 463 
dogs (15/18); the results were used to assess for underlying airway disease.  There are 464 
limitations relating to the cytological analysis of fluid and fine-needle aspirates of lung 465 
lesions may reflect the cells and pathology more accurately. [50]  It should be noted that ideally 466 
all dogs would have been screened for underlying lung pathology using bronchoscopy and 467 
Bronchoalveolar lavage examination, however this was not clinically indicated in the three 468 
dogs without respiratory signs. The clinical significance of a positive bacterial culture of the 469 
Bronchoalveolar lavage fluid documented in two dogs is unknown.  The pathogenesis of the 470 
bacteria cannot be fully identified, however is has been shown that coinfection by parasitic 471 
and bacterial infections do occur in a number of dogs.[3]  It is therefore difficult to assimilate 472 
which findings may be attributed to a bacterial bronchopneumonia or the verminous 473 
pneumonia.  Many of the dogs (16/18) were provided with symptomatic treatment (not 474 
including appropriate anthelmintic; Four dogs received corticosteroids, nine dogs received 475 
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antimicrobials and four dogs were given furosemide) in a primary care setting, prior to 476 
further investigations.  It is difficult to objectively assess how pharmaceutical administration 477 
may affect Bronchoalveolar lavage or CT examination findings. This is certainly a limitation 478 
of the study.  479 
A future prospective study may include a panel of veterinary radiologists, who are blinded to 480 
the clinical diagnosis, with the inclusion of dogs presenting with alternative pulmonary 481 
pathology, such as lymphoma, acute respiratory distress syndrome and other causes of non-482 
cardiogenic pulmonary oedema, allowing for comparisons of the description of the findings 483 
and distribution. Additionally, it would be beneficial to acquire repeat thoracic CT images 484 
following successful treatment; allowing for identification of any long-standing changes that 485 
may alter prognostication.  Follow up thoracic CT sequences were not performed on the dogs 486 
in this study; this may be due to various reasons, including clinical improvement of the dogs 487 
without a clinical rational to do so. There is interest in quantitative assessment of pulmonary 488 
pathology in human medicine and radiology, this could be an avenue explored to further 489 
objectify these findings.  490 
 491 
In conclusion, this study was the first to describe thoracic CT and clinical findings in a group 492 
of dogs with naturally infected A. vasorum.   Pulmonary changes and mild to moderate 493 
lymphadenomegaly were detected in all dogs.   Thoracic CT findings for naturally infected 494 
dogs took various appearances, with a considerable overlap with other pulmonary conditions. 495 
The predominant findings described in this study were a peripheral distribution of increased 496 
lung attenuation with diffuse, poorly organized and multifocal nodules that were of ground 497 
glass opacity. These findings echoed those previously reported on CT examination of six 498 
dogs experimentally infected with A.vasorum, yet they were not identical.  The clinical signs 499 
did not appear to be related to the degree of changes on thoracic CT in this small sample of 500 
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dogs.  501 
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Appendix 1:  Computed Tomography (CT) Technical Parameters for Eighteen Dogs included in 643 
the sample* 644 
Patient CT Scanner 
 
kV mAs Slice Thickness 
(mm) 
Matrix (Size) DFOV (cm) 
1 Siemens Somatom Spirit 130 27 3 512 x 512 30x30 
2 Siemens Somatom Spirit 130 32 3 512 x 512 22.4x22.4 
3 Siemens Somatom Spirit 130 29 3 512 x 512 16.7x16.7 
4 Siemens Somatom Spirit 130 40 3 512 x 512 31.1x31.1 
5 GE Medical HighSpeed 
Dual 
120 60 2 512 x 512 13x13 
6 GE Brightspeed 120 59 1.3 512 x 512 25x25 
7 Philips MX8000 IDT 16 120 129 2 512 x 512 19.6x19.6 
8 Philips MX8000 IDT 16 120 122 2 512 x 512 34.9x34.9 
9 Toshiba Aquilion Prime 120 100 0.5 512 x 512 20.5x20.5 
10 Toshiba Aquilion Prime 120 149 1 512 x 512 25.8x25.8 
11 Toshiba Aquilion Prime 120 142 1 512 x 512 22.1x22.1 
12 Toshiba Aquilion Prime 120 80 1 512 x 512 31.4x31.4 
13 GE Brightspeed 120 72 1.3 512 x 512 23.8 x23.8 
14 Siemens Emotion 16 130 24 3 512 x 512 22.3x22.3 
15 Philips MX8000 IDT 16 120 162 2 512 x 512 31x31 
16 Philips MX8000 IDT 16 120 138 2 512 x 512 19.6x19.6 
17 GE Medical HighSpeed 
Dual 
120 43 2 512x512 13x13 
18 GE Medical HighSpeed 
Dual 
120 115 5 512x512 20.2x20.2 
*Institutes involved: The University of Glasgow, Small Animal Hospital, School of 645 
Veterinary Medicine, College of Medical, Veterinary and Life Sciences, Bearsden, 646 
Glasgow, G61 1QH; The Royal Veterinary College, Hawkshead Lane, North 647 
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Mymms, Hatfield, Hertfordshire, AL9 7TA; Anderson Moores, The Granary, 648 
Bunstead Barns, Poles Lane, Hursley, Winchester, Hampshire, SO21 2LL; University 649 
of Liverpool, School of Veterinary Science, Leahurst Campus, Chester High Road, 650 
Neston, Wirral, CH64 7TE; Pride Veterinary Centre, Riverside Road, Pride Park, 651 
Derby DE24 8HX; School of Veterinary Medicine and Science, University of 652 
Nottingham, Sutton Bonington Campus, Leicestershire, LE12 5RD; University of 653 
Bristol, Langford Veterinary Services, Langford House, Langford, Bristol, BS40 5DU 654 
 655 
 656 
657 
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Table 1. Criteria Used to Classify Thoracic CT Findings. 658 
Classification Group Features 
0  No changes noted 
1 (Mild) Some or all zones affected, with predominately ground –glass 
opacity with only occasional areas of consolidation noted. 
2 (Moderate) All zones are affected, with multifocal areas of mixed attenuation 
(ground –glass opacity and mosaic attenuation) change affecting 
multiple, if not all, lobes. There is the occasional areas of 
consolidation observed. 
3 (Severe)  Multiple areas to diffuse changes in all zones with clear areas of 
marked hyperattenuation and consolidation resulting in loss of 
vascular margins. This is accompanied by marked ground-glass 
opacity. There may be co-existing features of bronchiectasis or air-
trapping resulting in a mosaic attenuation pattern. 
659 
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Appendix 2. Clinical and Thoracic CT Findings for 18 dogs with naturally occurring 660 
Angiostrongylus vasorum.† 661 
Dog Age 
(months) 
Breed Gender Weight 
(kg) 
Presenting 
complaint 
Onset CT Severity 
score 
1 3 Gold Retriever F 13 Respiratory signs Acute 3 
2 5 WHWT M 3.4 Respiratory signs Acute 3 
 
3 21 Dachshund FN 5.8 Respiratory signs Chronic 2 
 
4 35 Mini Schnauzer 
 
MN 12.3 Respiratory signs Chronic 3 
5 66 Cocker Spaniel 
 
M 14 Respiratory signs Chronic 3 
6 71 Basset Hound F 22.4 Respiratory signs Chronic 2 
7 75 Dalmatian M 36.1 Respiratory signs Chronic 3 
8 80 CKCS MN 15 Neurological, 
Respiratory signs 
Chronic 2 
9 84 Greyhound MN 27 Respiratory signs, 
Bleeding diathesis 
Acute 1 
10 89 Mini Schnauzer FN 7.7 Respiratory signs Acute 2 
11 94 Gold Retriever FN 34.4 Respiratory signs Chronic 2 
12 95 Gold Retriever MN 27 Respiratory signs Chronic 2 
13 100 Lurcher FN 27.2 Neurological, 
bleeding diathesis 
Acute 1 
14 119 SBT X M 15.1 Neurological Chronic 2 
15 121 Lab Retriever FN 27.9 Respiratory signs Acute 3 
16 129 SBT M 17.2 Respiratory signs Chronic 3 
17 140 Lab Retriever M 42.5 Respiratory signs Chronic 3 
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18 148 Gold Retriever F 26.2 Bleeding diathesis Chronic 1 
* M, male; F, female; MN, male neutered; FN, female neutered; CKCS, Cavalier King 662 
Charles Spaniel; Gold Retriever, Golden Retriever; Lab Retriever, Labrador Retriever; Mini 663 
Schnauzer, Miniature Schnauzer; SBT, Staffordshire Bull Terrier; WHWT, West Highland 664 
White Terrier; X, crossbred. 665 
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Figure legends 666 
 667 
Fig. 1 Transverse CT image of the thorax of a dog infected with A. vasorum obtained 668 
at the level of the right and left caudal lobes, and also includes the right accessory 669 
lung lobe (A).  The caudal thorax is shown with the right and left caudal lung lobes 670 
given a score of 1 demonstrating mild parenchymal lesions (B).  There are prominent 671 
parenchymal bands extending from the zone 1 into zone 2, with increased attenuation 672 
on the periphery of the lobe (black arrow head).  Areas of patchy soft tissue 673 
attenuation resulting in effacement of the pulmonary vasculature, suggesting 674 
consolidation, are identifiable ventrally and in the caudal lung field; this is identifiable 675 
in both the left and right hemithorax (white arrow).  Atelectasis (pertaining to 676 
cicatrisation, compression or dependent) may be considered as a possible cause of the 677 
radio-pathological sign.  There is an ill-defined area of increased attenuation (GGO) 678 
within zone 2 and zone 3 (black arrow). There is a degree of bronchiolectasis 679 
identified in the left caudal lobe, seen in the peribronchovascular and subpleural 680 
zones. Window width (WW) 1400, window Level (WL) -500. 681 
 682 
Fig. 2 Transverse CT images of the lungs of a dog at the level of the right accessory 683 
lung lobe (A) and the right caudal and left caudal lung lobes (B), given a score of 2 684 
(moderate changes).  All lung lobes are affected, with lesions most notable in the 685 
peripheral regions (zone 1 and 2).  There is rare central involvement (zone 3).  There 686 
was mosaic attenuation with multifocal regions of ground glass opacity (black arrow) 687 
and parenchymal consolidation (white arrow). Mild to moderate bronchiectasis and 688 
bronchiolectasis were diffusely noted and there was subtle subjective 689 
peribronchovascular thickening (peribronchial cuffing) denoted by the (black arrow 690 
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head).  The ventral and caudal portions of the right and left caudal lobes are affected 691 
with the central region (zone 3) spared. WW/WL 1400/-500. 692 
 693 
Fig. 3 Transverse CT image of the thorax of a dog naturally infected with A. vasorum 694 
and given a severity score 3 (severe) showing the level of the accessory, right middle 695 
and caudal and left caudal lobes (A) and at the level of the caudal area of the caudal 696 
lobes (B).  The increased opacity of the lung lobes may be due to anesthesia induced 697 
atelectasis, underlying pathology or a combination of both. The most prominent 698 
lesions are multifocal areas of coalescing consolidation within the zone 2 and zone 3 699 
(arrow heads); this appears base wide at the pleura.  There are ill-defined to well 700 
circumscribed, heterogeneous hyper attenuating nodules (-137HU to 36HU) 701 
compared to the surrounding parenchyma (white arrows) mean -508HU.  All lobes 702 
have a diffuse increase in attenuation (black arrows) with severe, diffuse 703 
consolidation (soft tissue attenuation).  The right middle is severely affected.  704 
WW/WL 1400/-500. 705 
 706 
 707 
